Your AI-Trained Oncology Knowledge Connection!
Video
Roy Herbst, MD, of Yale Cancer Center, reports on the FDA acting against companies illegally selling cancer treatments, an FDA clearance on a second scalp cooling system, promising phase III trials in breast cancer, and early findings with immunotherapy in liver cancer.
Jun 6th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 18th 2025 - Jun 19th 2026
Jun 6th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 18th 2025 - Jun 19th 2026
Jun 6th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval
PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer
BGB-16673 Displays a High ORR and Tolerability in Waldenström Macroglobulinemia
GI Cancer Experts on Notable Updates Shared During the 2025 ASCO Annual Meeting
2 Commerce Drive
Cranbury, NJ 08512